XML 33 R23.htm IDEA: XBRL DOCUMENT v2.4.0.6
LIQUIDITY AND SIGNIFICANT ACCOUNTING POLICIES: (Details 4) (USD $)
1 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended
Jun. 30, 2012
Apr. 30, 2012
Jun. 30, 2012
Jun. 30, 2011
Jun. 30, 2012
Jun. 30, 2011
Jun. 15, 2012
Jun. 30, 2012
Common Stock
Jun. 30, 2012
Common Stock
Jun. 30, 2012
Additional Paid-In Capital
Jun. 30, 2012
Additional Paid-In Capital
Jun. 30, 2012
Accumulated Deficit
Jun. 30, 2012
Accumulated Deficit
Jun. 30, 2012
Treasury Stock
Mar. 31, 2012
Treasury Stock
Sep. 30, 2011
Treasury Stock
Changes in Shareholders' Equity                                
BALANCE at the beginning of the period (in shares)   6,075,000 6,075,000   6,021,000   9,305,702 6,075,000 6,021,000         2,000 2,000 2,000
BALANCE at the beginning of the period   $ 4,712,000 $ 4,712,000   $ 5,554,000     $ 6,000 $ 6,000 $ 71,250,000 $ 70,988,000 $ (66,520,000) $ (65,416,000) $ (24,000) $ (24,000) $ (24,000)
Director restricted stock grants (in shares)                 54,000              
Director restricted stock grants         123,000           123,000          
Proceeds from sale of commons stock     3,000   3,000     3,000 3,000              
Issuance of shares for services     2,000   12,000         2,000 12,000          
Expense related to employee stock option grants     78,000   145,000         78,000 145,000          
Fees related to rights offering     (177,000)   (184,000)         (177,000) (184,000)          
Nonemployee option expense     8,000   19,000         8,000 19,000          
Warrant expense     (42,000)   (34,000)         (42,000) (34,000)          
Expense related to employee restricted stock grants rights offering         50,000           50,000          
Rights offering (in shares) 3,230,769 3,230,769           3,231,000 3,231,000              
Rights offering 4,200,000   4,197,000   4,197,000         4,197,000 4,197,000          
Net loss     (568,000) (140,000) (1,672,000) (660,000)           (568,000) (1,672,000)      
BALANCE at the end of the period (in shares) 9,305,000   9,305,000   9,305,000   9,305,702 9,306,000 9,306,000         2,000 2,000 2,000
BALANCE at the end of the period $ 8,213,000   $ 8,213,000   $ 8,213,000     $ 9,000 $ 9,000 $ 75,316,000 $ 75,316,000 $ (67,088,000) $ (67,088,000) $ (24,000) $ (24,000) $ (24,000)
Loss Per Share                                
Anti-dilutive shares     1,462,500   1,462,500